Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 65% ± 17% | |
lung | 11 studies | 38% ± 9% | |
bone marrow | 6 studies | 42% ± 16% | |
intestine | 5 studies | 30% ± 9% | |
kidney | 5 studies | 35% ± 17% | |
lymph node | 5 studies | 45% ± 11% | |
liver | 5 studies | 43% ± 16% | |
placenta | 3 studies | 28% ± 6% | |
thymus | 3 studies | 65% ± 30% | |
brain | 3 studies | 34% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1153.81 | 650 / 653 | 99% | 120.03 | 601 / 605 |
breast | 100% | 1935.19 | 459 / 459 | 96% | 36.89 | 1077 / 1118 |
lung | 100% | 3243.74 | 578 / 578 | 95% | 41.54 | 1102 / 1155 |
kidney | 98% | 922.75 | 87 / 89 | 92% | 59.85 | 828 / 901 |
bladder | 90% | 867.33 | 19 / 21 | 89% | 39.54 | 448 / 504 |
adrenal gland | 93% | 612.41 | 241 / 258 | 86% | 28.29 | 197 / 230 |
uterus | 88% | 541.29 | 150 / 170 | 90% | 31.80 | 414 / 459 |
intestine | 82% | 909.74 | 793 / 966 | 83% | 23.45 | 438 / 527 |
stomach | 74% | 421.20 | 264 / 359 | 86% | 22.53 | 245 / 286 |
prostate | 80% | 522.98 | 197 / 245 | 78% | 16.74 | 392 / 502 |
liver | 47% | 274.64 | 107 / 226 | 91% | 26.19 | 371 / 406 |
brain | 41% | 194.93 | 1085 / 2642 | 97% | 38.36 | 685 / 705 |
skin | 47% | 249.66 | 858 / 1809 | 90% | 46.64 | 423 / 472 |
esophagus | 62% | 346.56 | 891 / 1445 | 63% | 11.95 | 115 / 183 |
pancreas | 13% | 57.98 | 41 / 328 | 97% | 50.42 | 172 / 178 |
adipose | 100% | 2275.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 395.35 | 29 / 29 |
peripheral blood | 100% | 13304.70 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 9060.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 48.91 | 44 / 45 |
ovary | 24% | 122.44 | 43 / 180 | 70% | 13.36 | 299 / 430 |
blood vessel | 63% | 492.33 | 842 / 1335 | 0% | 0 | 0 / 0 |
heart | 55% | 275.93 | 472 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 29% | 6.25 | 23 / 80 |
muscle | 8% | 34.02 | 65 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0034316 | Biological process | negative regulation of Arp2/3 complex-mediated actin nucleation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0071846 | Biological process | actin filament debranching |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0071933 | Molecular function | Arp2/3 complex binding |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0003779 | Molecular function | actin binding |
GO_0008083 | Molecular function | growth factor activity |
Gene name | GMFG |
Protein name | Glia maturation factor gamma Glia maturation factor gamma (GMF-gamma) Glia maturation factor |
Synonyms | |
Description | |
Accessions | ENST00000709032.1 ENST00000594700.5 M0QXC2 M0QYJ8 M0QXZ6 O60234 M0R1D2 ENST00000602185.5 ENST00000600322.5 ENST00000598034.5 M0R0C1 ENST00000595207.5 M0QYG8 ENST00000253054.12 ENST00000595636.1 M0QX47 ENST00000601387.5 ENST00000596583.5 M0R2P2 ENST00000597595.6 |